Lamminen Terttu, Korpivaara Mira, Aspegrén John, Palestrini Clara, Overall Karen L
Research &Development, Orion Corporation Orion Pharma, 02100 Espoo, Finland.
Department of Veterinary Medicine, University of Milan, 20060 Lodi, Italy.
Animals (Basel). 2023 Jan 21;13(3):371. doi: 10.3390/ani13030371.
Cats frequently suffer from anxiety related to travel and veterinary visits. One sequela is avoidance of veterinary visits and lack of adequate veterinary care. The objective of this study was to test clinical efficacy and safety of a novel formulation of a pregabalin 50 mg/mL oral solution for alleviation of anxiety and fear in cats during transport and veterinary visits. A total of 209 client-owned cats were given either a flavored pregabalin oral solution at the dosage of 5 mg/kg (n = 108) or an identical placebo (n = 101) approximately 90 min before placing them into the carrier and transporting them in a car for at least 20 min to a veterinary clinic. The treatment effect using a 5-point numerical rating scale was evaluated during transportation by the owner and during clinical examination by the veterinarian, both blinded to the treatment. In addition, to verify the owner assessment, an external expert blinded to the treatment and owner assessment evaluated the transportation video recordings using the same rating scale as the owner. Pregabalin 5 mg/kg statistically significantly decreased both travel- ( < 0.01) and veterinary-visit- ( < 0.01) related anxiety compared to the placebo. The external expert's evaluation was in agreement with the owners' assessment confirming the treatment effect during transportation ( < 0.01). Treatment was well tolerated with only a few cats showing transient slight incoordination and tiredness. The flavored oral solution formulation with a small dosing volume of 0.1 mL/kg was found by the owners to be user-friendly and was well-accepted by the cats. This study demonstrated that a single oral dosage of the novel pregabalin oral solution alleviates anxiety and fear related to transportation and veterinary visits in cats, thus providing practical aid for both owners and veterinarians to enable cat-friendly handling and improving the welfare of cats in situations they often perceive as very stressful.
猫经常会因旅行和看兽医而焦虑。一个后果是避免看兽医以及缺乏足够的兽医护理。本研究的目的是测试一种新型的50毫克/毫升普瑞巴林口服溶液在减轻猫在运输和看兽医期间的焦虑和恐惧方面的临床疗效和安全性。总共209只宠物猫在被放入猫笼并用车运送到兽医诊所至少20分钟之前约90分钟,被给予5毫克/千克剂量的调味普瑞巴林口服溶液(n = 108)或相同的安慰剂(n = 101)。在运输过程中由主人使用5分数字评分量表评估治疗效果,在临床检查时由兽医评估,二者均对治疗不知情。此外,为了验证主人的评估,一位对治疗和主人评估不知情的外部专家使用与主人相同的评分量表评估运输视频记录。与安慰剂相比,5毫克/千克的普瑞巴林在统计学上显著降低了与旅行(<0.01)和看兽医(<0.01)相关的焦虑。外部专家的评估与主人的评估一致,证实了运输期间的治疗效果(<0.01)。治疗耐受性良好,只有少数猫表现出短暂的轻微共济失调和疲倦。主人发现0.1毫升/千克小剂量的调味口服溶液配方使用方便,并且猫很容易接受。这项研究表明,单次口服新型普瑞巴林口服溶液可减轻猫与运输和看兽医相关的焦虑和恐惧,从而为宠物主人和兽医提供实际帮助,以便在猫通常认为非常紧张的情况下实现对猫友好的处理并改善猫的福利。